| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |